Kate Rapi
@KateRapi
Haematologist, MSc *tweets are my own
'Less is more' maintenance therapy in #MultipleMyeloma! Triplets→ASCT→3yr Len → D/C if MRD-neg (NGF+PET/CT-neg) Results: 3yr PFS ~93%, TFS ~75% *Treatment initiated for MRD resurgence Based on @bdermanmd 's MRD2STOP + this data: I'm comfortable stopping Len in standard-risk…
Now in @BloodJournal: congrats @thanosdimop et al on studying this prospectively! I love the abstract! Stopping len is a burning question for the #MMsm community and can also stop burning holes in our pocketbooks 💸 Good to see such great post-discontinuation PFS data here!
Just published! Updated EHA-EMN guidelines for the diagnosis, treatment and follow-up of #MultipleMyeloma! #mmsm nature.com/articles/s4157… @EHA_Hematology @EMN_EuMMnet @UoATherapeutics
The paper of the day: a landmark publication that is bound to serve as a reference for years to come! @NatRevClinOncol @thanosdimop @COMyCongress @TheIACH @mbeksac56
On being a good doctor. The number of research publications don’t tell you how good a doctor is at being a doctor. Neither do the number of book chapters or grants. Or academic rank. It’s a different skill set. Good doctors have stellar clinical acumen & empathy. #MedTwitter
On being a good doctor Part II (after being on the other side as a patient advocate) - Understand the patient and the clinical problem they face. It is more than just analyzing lab results and scans. 90% of diagnosis is history. - History taking/acquisition is a skill.…
Looking forward to speaking on treatment of High-risk #myeloma at @EHA_Hematology conference in Milano in June - many thanks @Myeloma_Society and EHA for invite. In the meantime, hope people might enjoy our @BritSocHaem podcast on this topic: podbean.com/ew/pb-2734e-17…
Beth Jacobson reached out to Dr. Folkman upon Dr. Bergsagel’s suggestion. Dr. Folkman mentioned his idea of using thalidomide to treat cancer. She felt thalidomide can work for myeloma and mentioned it to Dr. Bart Barlogie at University of Arkansas who was treating her husband.…
Bispecific antibodies are safe and effective in frail and elderly patients with multiple myeloma. No difference in CRS, ICANS, TRM or ORR compared to non-frail #mmsm #bmtsm @BloodAdvances @hhashmi87 @szusmani ashpublications.org/bloodadvances/…
Great paper especially BRAf would be an interesting option to target
Amazing discussions during the first session of the @COMyCongress @TheIACH @RaabMarc @NBahlis @EileenMBoyle
#Myeloma Paper of the Day: Multiomic analysis of #Waldenström macroglobulinemia finds two disease subtypes, including memory B-cell-like (MBC-like) & plasma cell-like (PC-like) w/ distinct epigenetic, mutational, transcriptional & clinical features: pubmed.ncbi.nlm.nih.gov/40332467/. #mmsm
Researchers, including Drs. Jan Frenking and @RaabMarc from @uniklinik_hd, highlight that bridging intensity distinctly shapes the trajectory of #hematopoietic recovery after B-cell maturation antigen CAR-T. 📚 More in @BloodAdvances: bit.ly/4jT2Kvu
Weekend highlight: GMMG Spring Meeting in Hamburg. Marc’s (@RaabMarc) talk on upcoming clinical studies was, as always, spot on, clear, inspiring, & a solid look at what’s ahead. Plenty of work on the horizon, but honestly… I’m looking forward to it. #mmsm



The relief I am able to provide my patients is often not the specific tests or the treatments I prescribe. It’s the time spent explaining and reassuring. The human touch is important for healing and peace of mind. No computer can provide that. #MedTwitter
Do you need any more reason why meetings in Glasgow rock!!! Best poster session ever. @BritSocHaem
Which SMM patients should we treat and how? Do all need double maintenance ? Quads for each and everyone? Sagar Lonial @SagarLonialMD Elias Mai @EliasKarlMai Shaji Kumar @myelomaMD Philippe Moreau
See you all in 2027 for the 11th Heidelberg Myeloma Workshop
Second day of the 10th Heidelberg Myeloma Workshop How to further improve on CAR-Ts? @KRejeski @szusmani @H_Einsele @JHillengass Jens Lohr #mmsm
Great first day of the 10th Heidelberg Myeloma Workshop! Many new insights and thought-provoking ideas #mmsm